Weight loss, diabetes drugs propel Eli Lilly to largely better-than-expected forecast for 2024Eli Lilly rode soaring demand for diabetes and weight-loss treatments to a better-than-expected finish in 2023, and the drugmaker expects momentum to carry into the new year.
Eli Lilly starts website to connect patients with new obesity treatment, Zepbound, other drugsEli Lilly has launched a unique website to connect U.S. patients seeking obesity treatment to doctors, dieticians and its new weight-loss drug, Zepbound.
Lilly plans to slash some insulin prices, expand cost capEli Lilly will cut prices for some older insulins later this year and immediately give more patients access to a cap on the costs they pay to fill prescriptions.